Macrogenics Earnings Preview

Macrogenics (NASDAQ:MGNX) is preparing to release its quarterly earnings on Tuesday, 2024-11-05. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Macrogenics to report an earnings per share (EPS) of $0.21.

The market awaits Macrogenics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Performance in Previous Earnings

The company's EPS missed by $0.30 in the last quarter, leading to a 7.14% drop in the share price on the following day.

Here's a look at Macrogenics's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

-0.59

-0.64

-0.15

-0.10

EPS Actual

-0.89

-0.84

-0.75

0.28

Price Change %

-7.000000000000001%

-77.0%

-15.0%

17.0%

Tracking Macrogenics's Stock Performance

Shares of Macrogenics were trading at $3.87 as of November 01. Over the last 52-week period, shares are down 41.99%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Analyst Views on Macrogenics

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Macrogenics.

Analysts have provided Macrogenics with 4 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at ...